Author sees potential upside in FMC due to low valuation and innovation if new products succeed.
FMC — WATCH Author notes FMC trades at 0.5x price-to-book and 20-year lows, and argues that known patent expirations are offset by innovation. If some new products do well, there is a lot of upside, and the author suspects the tough next couple of years may already be priced in.
Has a 0.5x p/b ratio and is trading at 20 year lows. I know that a lot of their products have patents expiring but they are known to innovate a lot. If some of their new products do well is there not a lot of upside? Think FMC could have a tough next couple of years but isn’t this already (over) priced in.